RFX6 Gene Mutation can Lead to a New Type of Diabetes

by Rishika Gupta on  October 14, 2017 at 11:41 AM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

Genetic mutation in RFX6 gene can lead to a new type of diabetes found a new study published in Nature communications journal.
 RFX6 Gene Mutation can Lead to a New Type of Diabetes
RFX6 Gene Mutation can Lead to a New Type of Diabetes

A Scientific research team at the ULB Center for Diabetes Research and the Erasmus Hospital of the ULB has led to the identification of a new type of diabetes caused by a mutation in the gene RFX6.

Show Full Article


Scientists from the ULB Center for Diabetes Research and the Erasmus Hospital of the ULB, together with colleagues at the University of Exeter (UK), University of Helsinki (Finland) and Kyoto University (Japan), have identified a new type of diabetes caused by a mutation in the gene RFX6.

Individuals carrying the RFX6 mutation have a high probability of developing diabetes: it can start early, before the age of 20 years, and by the age of 50 years, 80% of the patients might have developed the disease.

It is transmitted from parents to children and may affect many generations in the same family. RFX6 diabetes often requires insulin treatment because patients have reduced insulin secretion by the pancreas.

Dr. Miriam Cnop, Professor at the ULB Center for Diabetes Research and the Erasmus Hospital, identified in these patients a reduced production of the hormone GIP( Gastric Inhibitory Peptide ) that stimulates insulin secretion.

The hormone GIP is produced by the intestine after eating and is an important regulator of insulin secretion.

RFX6 diabetes is the first type of diabetes discovered to be related to low GIP production.

The identification of this novel disease mechanism suggests that GIP analogs ( drugs with a structure similar to GIP) may provide a novel treatment option for patients with RFX6 diabetes.

These new observations emphasize the need to identify specific forms of diabetes to provide personalized therapy to patients.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive